#PreMarket Losers

Gainers Repros Therapeutics Inc (NASDAQ: RPRX) shares rose 56.67 percent to $1.280 in pre-market trading after the company reported that patients receiving 6 and 12 mg doses of Proellex achieved significant reduction in excessive menstrual bleeding, the key symptom of uterine fibroids. The...

Gainers Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) rose 10.33 percent to $2.03 in pre-market trading after the company reported favorable results from Phase 1b trial of APD371. Amicus Therapeutics, Inc. (NASDAQ: FOLD) shares rose 8.70 percent to $8.50 in pre-market trading after dropping...

Gainers Hatteras Financial Corp. (NYSE: HTS) rose 10.03 percent to $15.69 in pre-market trading after Annaly Capital Management, Inc. (NYSE: NLY) announced plans to acquire Hatteras Financial for $1.5 billion. Seagate Technology PLC (NASDAQ: STX) shares rose 3.16 percent to $34.28 in pre-...

Gainers Anavex Life Sciences Corp. (NASDAQ: AVXL) rose 15.60 percent to $6.15 in pre-market trading as the company reported that it has received the FDA approval for Orphan Drug Designation for Frontotemporal dementia treatment. Depomed Inc (NASDAQ: DEPO) shares rose 11.80 percent to $16.77 in...

Gainers Wynn Resorts, Limited (NASDAQ: WYNN) shares rose 6.62 percent to $95.48 in pre-market trading as the company announced Wynn Paradise Park in Las Vegas. Valeant Pharmaceuticals Intl Inc (NYSE: VRX) shares gained 6.62 percent to $36.40 in pre-market trading after Board member and...

Gainers Glu Mobile Inc. (NASDAQ: GLUU) shares rose 8.36 percent to $3.24 in pre-market trading after gaining 10.74 percent on Tuesday. Sarepta Therapeutics Inc (NASDAQ: SRPT) shares rose 7.27 percent to $20.95 in pre-market trading. Oppenheimer maintained Outperform rating and raised the...

Gainers Intercept Pharmaceuticals Inc (NASDAQ: ICPT) shares rose 10.82 percent to $148.00 in pre-market trading following release of the FDA Advisory Committee documents. Vitae Pharmaceuticals Inc (NASDAQ: VTAE) shares rose 3.48 percent to $7.13 in pre-market trading after gaining 2.84...

Gainers Virgin America Inc (NASDAQ: VA) shares rose 39.20 percent to $54.15 in pre-market trading after Alaska Air Group confirmed it has entered into an agreement to acquire the airline for $57.00 per share in cash. Zafgen Inc (NASDAQ: ZFGN) rose 14.63 percent to $7.68 in pre-market...

Gainers TerraForm Power Inc (NASDAQ: TERP) shares rose 7.51 percent to $9.30 in pre-market trading. Tepper raised stake in Terraform from 9.5 percent to 10.9 percent. Tesla Motors Inc (NASDAQ: TSLA) shares rose 6.63 percent to $245.00 in pre-market trading following Thursday night's Model 3...

Gainers Medivation Inc (NASDAQ: MDVN) shares rose 12.20 percent to $41.95 in pre-market trading amid word of a new report from Bloomberg, saying the company is working with bankers to defend itself against preliminary interest of a takeover. However, Reuters separately reported the company is...

Gainers ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) rose 24.07 percent to $29.54 in pre-market trading. A U.S. Food and Drug Administration panel voted 12-2 on Tuesday that Acadia's drug pimavanserin, a treatment for psychosis associated with Parkinson's disease, outweighed the risks...

Gainers Cleco Corporation (NYSE: CNL) rose 13.31 percent to $55.26 in pre-market trading after the company confirmed that the Louisiana Public Service Commission (LPSC) voted to approve a sale of the company. Ambarella Inc (NASDAQ: AMBA) shares rose 6.34 percent to $43.29 in pre-market...

Gainers ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) rose 14.23 percent to $23.20 in pre-market trading after gaining 0.30 percent on Thursday. Centrus Energy Corp (NYSE: LEU) shares rose 13.89 percent to $3.69 in pre-market trading following the announcement of a $32 million contract...

Gainers KB Home (NYSE: KBH) rose 5.97 percent to $13.85 in pre-market trading as the company reported stronger-than-expected results for its first quarter on Wednesday. Finish Line Inc (NASDAQ: FINL) shares rose 3.22 percent to $19.55 in pre-market trading after the company reported...

Gainers Ionis Pharmaceuticals Inc (NASDAQ: IONS) shares rose 11.38 percent to $46.50 in pre-market trading. Ionis Pharmaceuticals and Merck reported that they have received positive verdict on Gilead’s HCV drug patent case. Affymetrix, Inc. (NASDAQ: AFFX) rose 3.34 percent to $14.85...